Liang Liu Selected Research

JCICM-6

2/2006

Suppressive effects of JCICM-6, the extract of an anti-arthritic herbal formula, on the experimental inflammatory and nociceptive models in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liang Liu Research Topics

Disease

254	Neoplasms (Cancer) 09/2022 - 09/2004
50	Inflammation (Inflammations) 06/2022 - 01/2005
44	Pancreatic Neoplasms (Pancreatic Cancer) 07/2022 - 01/2013
40	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022 - 11/2012
39	Neoplasm Metastasis (Metastasis) 07/2022 - 01/2010
36	Lung Neoplasms (Lung Cancer) 07/2022 - 11/2010
36	Rheumatoid Arthritis 06/2022 - 01/2004
31	Breast Neoplasms (Breast Cancer) 06/2021 - 02/2006
29	Glioma (Gliomas) 11/2022 - 08/2011
23	Adenocarcinoma 01/2021 - 09/2004
23	Carcinogenesis 01/2021 - 12/2003
22	COVID-19 12/2022 - 01/2020
22	Arthritis (Polyarthritis) 06/2022 - 11/2005
19	Hepatocellular Carcinoma (Hepatoma) 12/2021 - 01/2010
18	Hypoxia (Hypoxemia) 01/2022 - 05/2010
17	Poisoning 03/2022 - 01/2004
16	Carcinoma (Carcinomatosis) 05/2021 - 12/2002
15	Infections 01/2022 - 05/2007
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2013
13	Wounds and Injuries (Trauma) 03/2022 - 05/2005
11	Fibrosis (Cirrhosis) 09/2022 - 12/2012
11	Edema (Dropsy) 01/2022 - 01/2005
11	Osteoarthritis 01/2022 - 03/2014
10	Adenocarcinoma of Lung 05/2022 - 01/2016
10	Alzheimer Disease (Alzheimer's Disease) 03/2022 - 01/2013
10	Myocardial Infarction 01/2022 - 08/2010
10	Disease Progression 01/2022 - 11/2008
10	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 11/2013
10	Body Weight (Weight, Body) 01/2018 - 05/2006
9	Pain (Aches) 01/2022 - 06/2008
9	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 10/2015
9	Necrosis 11/2020 - 11/2007
8	Glaucoma 01/2022 - 01/2016
8	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2006
8	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 06/2006
8	Reperfusion Injury 09/2020 - 11/2010
8	Ischemia 09/2020 - 08/2006
7	Non-alcoholic Fatty Liver Disease 03/2022 - 01/2015
7	Esophageal Squamous Cell Carcinoma 02/2022 - 10/2013
7	Osteoporosis 01/2022 - 12/2005
7	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2014
7	Atherosclerosis 01/2022 - 05/2005
7	Melanoma (Melanoma, Malignant) 01/2022 - 10/2017
7	Stroke (Strokes) 01/2022 - 05/2011
7	Diabetic Nephropathies (Diabetic Nephropathy) 03/2019 - 06/2015
7	Experimental Arthritis 01/2019 - 11/2008
6	Brain Injuries (Brain Injury) 01/2022 - 08/2006
6	Cerebral Hemorrhage 01/2022 - 10/2016

Drug/Important Bio-Agent (IBA)

89	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2010
65	Pharmaceutical PreparationsIBA 12/2022 - 02/2004
65	Biomarkers (Surrogate Marker)IBA 05/2022 - 03/2010
31	CytokinesIBA 03/2022 - 01/2004
29	Messenger RNA (mRNA)IBA 01/2022 - 02/2006
23	Long Noncoding RNAIBA 03/2022 - 07/2015
22	Biological ProductsIBA 01/2022 - 01/2013
22	MicroRNAs (MicroRNA)IBA 12/2021 - 03/2013
20	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2003
19	EnzymesIBA 10/2021 - 07/2009
18	AntigensIBA 01/2022 - 02/2012
17	LipidsIBA 03/2022 - 08/2014
16	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 05/2010
16	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2014
16	Retinaldehyde (Retinal)IBA 01/2021 - 03/2014
15	sinomenineIBA 06/2022 - 10/2008
14	Therapeutic UsesIBA 01/2022 - 04/2006
13	Phosphotransferases (Kinase)IBA 02/2022 - 05/2005
11	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2007
11	CarbohydratesIBA 01/2019 - 12/2013
10	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 07/2015
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2022 - 11/2007
9	AlkaloidsIBA 01/2022 - 05/2008
9	Adenosine Triphosphate (ATP)IBA 05/2021 - 07/2011
9	Small Interfering RNA (siRNA)IBA 01/2021 - 07/2015
9	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2012
9	CalciumIBA 01/2020 - 07/2011
9	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019 - 11/2013
8	CollagenIBA 01/2022 - 12/2005
8	Methotrexate (Mexate)FDA LinkGeneric 12/2021 - 10/2018
8	Peptides (Polypeptides)IBA 10/2021 - 04/2014
8	ErbB Receptors (EGF Receptor)IBA 09/2020 - 01/2007
8	Gefitinib (Iressa)FDA Link 01/2020 - 03/2014
7	Temozolomide (Temodar)FDA LinkGeneric 03/2022 - 12/2017
7	Caspase 3 (Caspase-3)IBA 01/2022 - 07/2015
7	LigandsIBA 01/2022 - 03/2014
7	Neuroprotective AgentsIBA 01/2021 - 11/2015
7	GinsenosidesIBA 01/2020 - 11/2010
6	Circular RNAIBA 11/2022 - 01/2021
6	CarrageenanIBA 01/2022 - 02/2006
6	Immune Checkpoint InhibitorsIBA 01/2022 - 10/2020
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2021 - 01/2010
6	celastrolIBA 11/2021 - 03/2014

Therapy/Procedure

107	Therapeutics 05/2022 - 10/2006
41	Drug Therapy (Chemotherapy) 09/2022 - 01/2010
25	Immunotherapy 09/2022 - 03/2012
13	Radiotherapy 01/2022 - 12/2002
12	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2021 - 06/2012
9	Pancreatectomy 01/2021 - 12/2013
8	Neoadjuvant Therapy 07/2022 - 01/2018
7	Aftercare (After-Treatment) 01/2021 - 08/2015
6	Oral Administration 07/2021 - 03/2007